Category: News

DRI Healthcare Trust Announces Voting Results of AGM

TORONTO, May 11, 2022 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) is pleased to announce results of voting at its annual general meeting (“AGM”) of unitholders held on May 11, 2022. All of the nominees for election as trustees of the Trust referred to in its management information circular dated March […]

DRI Healthcare Trust Reports First Quarter 2022 Results

– Continued strong performance of existing assets and financial results – – Completion of Vonjo™ royalty transaction – TORONTO, May 10, 2022 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) today announced its financial results for the quarter ended March 31, 2022. The Trust’s first quarter 2022 financial statements and Management’s Discussion […]

DRI Healthcare Trust Announces Participation in Upcoming Investor Conferences

TORONTO, April 27, 2022 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) today announced that the Trust will participate in the following investor conferences in the month of May: Bloom Burton & Co. Healthcare Investor Conference Date: May 2, 2022 Presentation time: 9:30 am ET City: Toronto, Ontario Event URL: […]

DRI Healthcare Trust to Host First Quarter Earnings Call and Webcast on May 11, 2022

TORONTO, April 27, 2022 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today it will hold a conference call to discuss its first quarter 2022 financial results on Wednesday, May 11, 2022, at 8:00 a.m. ET. The Trust will report its financial results on Tuesday, May 10, 2022, after […]

DRI Healthcare Trust Announces Upsized Credit Facility

TORONTO, April 20, 2022 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today that a subsidiary of the Trust has entered into an amended and restated credit agreement (the “Amended Agreement”) with a syndicate of banks regarding US$350 million of credit facilities (the “Facilities”). The Amended Agreement increases the […]

DRI Healthcare Trust Reports Fourth Quarter and Fiscal 2021 Results

– Announced growth-oriented and accretive transactions of up to $186 million – – Continued strong performance of existing assets and financial results – – Acquired over one million units under Normal Course Issuer Bid – TORONTO, March 7, 2022 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) today announced its financial […]

DRI Healthcare Trust Comments on FDA Approval of VONJO (pacritinib)

TORONTO, March 1, 2022 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI”) today announced that it has been notified by CTI BioPharma Corp. (“CTI”) that the U.S. Food and Drug Administration (“FDA”) has approved VONJO (pacritinib) for the treatment of adults with intermediate or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis […]

DRI Healthcare Trust Declares Special Distributions

TORONTO, Dec. 22, 2021 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) today announced that its Board of Trustees has declared a special cash distribution in the amount of US$0.22 per trust unit. The special cash distribution will be made payable to unitholders of record at the close of business […]

DRI Healthcare Trust Comments on Extension of Review Period for pacritinib

TORONTO, Nov. 30, 2021 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) today announced that it has been notified by CTI BioPharma Corp. (CTI) that the U.S. Food and Drug Administration (FDA) has extended the review period for the New Drug Application for pacritinib for the treatment of adult Myelofibrosis […]